Ouvrir le menu principal

HOPE Étudiant β

Examiner des modifications individuelles

Navigation du filtre antiabus (Accueil | Modifications récentes des filtres | Examiner les modifications précédentes | Journal antiabus)

Cette page vous permet d'examiner les variables générées pour une modification individuelle par le filtre antiabus et de les tester avec les filtres.

Variables générées pour cette modification

VariableValeur
Si la modification est marquée comme mineure ou non (minor_edit)
Nom du compte d’utilisateur (user_name)
PrestonBarcenas
Groupes (y compris implicites) dont l'utilisateur est membre (user_groups)
* user autoconfirmed
Si un utilisateur est ou non en cours de modification via l’interface mobile (user_mobile)
Numéro de la page (article_articleid)
0
Espace de noms de la page (article_namespace)
0
Titre de la page (sans l'espace de noms) (article_text)
Aust Nuclear Scientists Fight Superbugs
Titre complet de la page (article_prefixedtext)
Aust Nuclear Scientists Fight Superbugs
Action (action)
edit
Résumé/motif de la modification (summary)
Ancien modèle de contenu (old_content_model)
Nouveau modèle de contenu (new_content_model)
wikitext
Ancien texte de la page, avant la modification (old_wikitext)
Nouveau texte de la page, après la modification (new_wikitext)
<br>Antibiotics aren't enough to keep superbugs at bay anymore but an Australian research team is trying to combat resistant bacteria using nuclear technology.<br> <br>The World Health Organisation has declared antimicrobial resistance one of the top 10 global health threats facing humanity and says overuse of antibiotics is the main driver of drug-resistant superbugs.<br> <br>Some bacteria are hard to treat because they are surrounded by an outer membrane that acts as a barrier preventing [https://www.business-opportunities.biz/?s=antibiotics antibiotics] from reaching their targets inside the bacteria.<br> <br>Scientists from Monash University, the Australian Nuclear Science and Technology Organisation and CSIRO have published a study in the journal Nature Communications into how a new treatment interacted with the bacterial outer membrane.<br> <br>Using nanoparticle technology, the researchers are harnessing cubosomes, which are liquid crystalline particles, as potential new vehicles for drug delivery to reach and target bacteria.<br> <br>A class of antibiotics drugs called polymyxins, which break up that outer membrane and themselves are relatively toxic, Quick Fix Urine; [https://quick-fix-urine.blogspot.com/search/label/Drug%20Testing https://quick-fix-urine.blogspot.com], are used as a last-line therapy.<br> <br>"We were looking at new approaches for delivering antibiotics to an infection site and found the cubosome - the delivery vehicle itself - has antimicrobial properties when binding to the surface of bacteria," ANSTO researcher Anton Le Brun said.<br> <br>They used a beamline instrument called a neutron reflectometer to see how cubosomes interact with the bacteria's surface.<br> <br>"Essentially, the polymyxin drug is the hitchhiker and the cubosome is the vehicle and in testing together they were more effectively able to crash through the outer barrier of the bacteria," Mr Le Brun said.<br> <br>Even though it's early days and the scientists are in testing mode, they believe the use of nanoparticles-antibiotics combination therapy could in the long run wean people off taking many antibiotics at the same time.<br> <br>The next step for scientists will be to consider which properties of the cubosome give them an antibiotic effect, and how they can be leveraged to deliver treatments.<br><br><br>adverts.addToArray({"pos":"inread_player"})Advertisement
Diff unifié des changements faits lors de la modification (edit_diff)
@@ -1,1 +1,1 @@ - +<br>Antibiotics aren't enough to keep superbugs at bay anymore but an Australian research team is trying to combat resistant bacteria using nuclear technology.<br> <br>The World Health Organisation has declared antimicrobial resistance one of the top 10 global health threats facing humanity and says overuse of antibiotics is the main driver of drug-resistant superbugs.<br> <br>Some bacteria are hard to treat because they are surrounded by an outer membrane that acts as a barrier preventing [https://www.business-opportunities.biz/?s=antibiotics antibiotics] from reaching their targets inside the bacteria.<br> <br>Scientists from Monash University, the Australian Nuclear Science and Technology Organisation and CSIRO have published a study in the journal Nature Communications into how a new treatment interacted with the bacterial outer membrane.<br> <br>Using nanoparticle technology, the researchers are harnessing cubosomes, which are liquid crystalline particles, as potential new vehicles for drug delivery to reach and target bacteria.<br> <br>A class of antibiotics drugs called polymyxins, which break up that outer membrane and themselves are relatively toxic, Quick Fix Urine; [https://quick-fix-urine.blogspot.com/search/label/Drug%20Testing https://quick-fix-urine.blogspot.com], are used as a last-line therapy.<br> <br>"We were looking at new approaches for delivering antibiotics to an infection site and found the cubosome - the delivery vehicle itself - has antimicrobial properties when binding to the surface of bacteria," ANSTO researcher Anton Le Brun said.<br> <br>They used a beamline instrument called a neutron reflectometer to see how cubosomes interact with the bacteria's surface.<br> <br>"Essentially, the polymyxin drug is the hitchhiker and the cubosome is the vehicle and in testing together they were more effectively able to crash through the outer barrier of the bacteria," Mr Le Brun said.<br> <br>Even though it's early days and the scientists are in testing mode, they believe the use of nanoparticles-antibiotics combination therapy could in the long run wean people off taking many antibiotics at the same time.<br> <br>The next step for scientists will be to consider which properties of the cubosome give them an antibiotic effect, and how they can be leveraged to deliver treatments.<br><br><br>adverts.addToArray({"pos":"inread_player"})Advertisement
Lignes ajoutées lors de la modification (added_lines)
<br>Antibiotics aren't enough to keep superbugs at bay anymore but an Australian research team is trying to combat resistant bacteria using nuclear technology.<br> <br>The World Health Organisation has declared antimicrobial resistance one of the top 10 global health threats facing humanity and says overuse of antibiotics is the main driver of drug-resistant superbugs.<br> <br>Some bacteria are hard to treat because they are surrounded by an outer membrane that acts as a barrier preventing [https://www.business-opportunities.biz/?s=antibiotics antibiotics] from reaching their targets inside the bacteria.<br> <br>Scientists from Monash University, the Australian Nuclear Science and Technology Organisation and CSIRO have published a study in the journal Nature Communications into how a new treatment interacted with the bacterial outer membrane.<br> <br>Using nanoparticle technology, the researchers are harnessing cubosomes, which are liquid crystalline particles, as potential new vehicles for drug delivery to reach and target bacteria.<br> <br>A class of antibiotics drugs called polymyxins, which break up that outer membrane and themselves are relatively toxic, Quick Fix Urine; [https://quick-fix-urine.blogspot.com/search/label/Drug%20Testing https://quick-fix-urine.blogspot.com], are used as a last-line therapy.<br> <br>"We were looking at new approaches for delivering antibiotics to an infection site and found the cubosome - the delivery vehicle itself - has antimicrobial properties when binding to the surface of bacteria," ANSTO researcher Anton Le Brun said.<br> <br>They used a beamline instrument called a neutron reflectometer to see how cubosomes interact with the bacteria's surface.<br> <br>"Essentially, the polymyxin drug is the hitchhiker and the cubosome is the vehicle and in testing together they were more effectively able to crash through the outer barrier of the bacteria," Mr Le Brun said.<br> <br>Even though it's early days and the scientists are in testing mode, they believe the use of nanoparticles-antibiotics combination therapy could in the long run wean people off taking many antibiotics at the same time.<br> <br>The next step for scientists will be to consider which properties of the cubosome give them an antibiotic effect, and how they can be leveraged to deliver treatments.<br><br><br>adverts.addToArray({"pos":"inread_player"})Advertisement
Horodatage Unix de la modification (timestamp)
1657151727